• About Us
    • Overview
    • Education
    • Mission & History
    • Board of Directors
    • The Campus
    • Careers
  • Our Achievements
    • Overview
    • Cancer
    • Technology
    • Education
    • Our Planet
    • Health & Medicine
    • Physical World
  • Get Involved
    • Overview
    • Partners in Science
    • Estate & Planned Giving
    • Attend an Event
    • Gift Opportunities
  • News & Media
    • Overview
    • News & Media Archive
    • Coronavirus
    • Feature Stories
    • News Releases
    • In The News
    • Video Gallery
    • Ad Campaigns
    • Celebrating Great Minds
  • Blog
  • Contact
  • Donate
Donate
Donate
About Us tri
About Us Overview
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
About Us

Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.

Our Achievements tri
Our Achievements Overview
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Our Achievements

The Weizmann Institute’s fundamental research has led to discoveries and applications with a major impact on the scientific community and on the quality of life for millions worldwide.

Get Involved tri
Get Involved Overview
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
Get Involved

Join a community of dedicated people who share the Weizmann Institute’s commitment to shaping a better world through science.

News & Media tri
News & Media Overview
  • News & Media Archive
  • Coronavirus
  • Feature Stories
  • News Releases
  • In The News
  • Video Gallery
  • Ad Campaigns
  • Celebrating Great Minds
News & Media

Learn about the Weizmann Institute’s latest groundbreaking discoveries and the American Committee’s activities across the country.

Blog tri
  • The Curiosity Review
Blog

Popular science for the curious-minded: The Curiosity Review brings discovery to life.

Contact

Search Results

  • SEARCH BY KEYWORD
  • SEARCH BY TAG
View Articles by Tag:
  • View Articles by Tag
  • Algorithims (6)
  • Alternative energy (27)
  • Alzheimers (44)
  • Archaeology (37)
  • Artificial intelligence (20)
  • Astrophysics (108)
  • Autism (22)
  • Awards (119)
  • Bacteria (107)
  • Behavior (9)
  • Biochemistry (101)
  • Biofuel (7)
  • Biology (309)
  • Biomolecular sciences (7)
  • Blood (43)
  • Brain (175)
  • Cancer (163)
  • Cancer treatment (127)
  • Central nervous system (9)
  • Chemistry (78)
  • Children (7)
  • Circadian clock (1)
  • Climate change (73)
  • Clinical trials (40)
  • Collaborations (19)
  • Community (279)
  • Computers (73)
  • Copaxone (12)
  • Coronavirus (7)
  • Culture (359)
  • Diabetes (32)
  • Earth (74)
  • Education (157)
  • Environment (92)
  • Enzymes (29)
  • Evolution (89)
  • Fertility (20)
  • Fungus (4)
  • Genetics (109)
  • Genomics (3)
  • Heart (5)
  • Heart disease (3)
  • Humanity (83)
  • Immune system (149)
  • Immunology (10)
  • Immunotherapy (34)
  • Inflammation (19)
  • Leadership (114)
  • Leukemia (12)
  • Materials (44)
  • Mathematics (62)
  • Medicine (84)
  • Memory (39)
  • Mental health (58)
  • Metabolism (51)
  • Microbiology (2)
  • Microbiome (10)
  • Molecular cell biology (9)
  • Molecular genetics (61)
  • Multiple sclerosis (12)
  • Nanoscience (33)
  • Nature (4)
  • Neurobiology (2)
  • Neuroscience (207)
  • Nutrition (72)
  • Optics (34)
  • Organs (11)
  • Parkinsons (11)
  • Personalized medicine (5)
  • Philanthropy (148)
  • Physics (139)
  • Plants (56)
  • Proteins (96)
  • Quantum computer (3)
  • Quantum physics (2)
  • Quantum theory (34)
  • Robots (8)
  • Security (21)
  • Senses (115)
  • Sensors (8)
  • Smoking (1)
  • Solar power (19)
  • Space (110)
  • Stem cells (49)
  • Technology (206)
  • Vaccine (40)
  • Virus (135)
  • Water (40)
  • Weather (1)
  • Women (115)
  • World hunger (17)
Filter by Time:
  • All
  • Past Day
  • Past Week
  • Past Month
  • Past Year
  • Past Three Years
Clear Filters

127 results for Cancer treatment

Looking Back, Looking Forward
Looking Back, Looking Forward

https://www.weizmann-usa.org/news-media/feature-stories/looking-back-looking-forward/

Apr 11, 2016... In a place that fosters curiosity and the pursuit of "what if," where scientists come to work every day with the knowledge that anything can happen, astounding discoveries are realized on a regular basis. That place is the Weizmann Institute of Science, where accomplishments are so remarkable and varied that, at times, we need to pause and take it all in. The beginning of a new year is just such a time.

TAGS: Astrophysics, Environment, Cancer treatment, Nutrition, Quantum theory

One Patent, Three Drugs
One Patent, Three Drugs

https://www.weizmann-usa.org/news-media/news-releases/one-patent-three-drugs/

Mar 16, 2016... A protocol that arose from Weizmann Institute of Science research has led to U.S. Food and Drug Administration (FDA) approval of a new biological drug for the treatment of a certain form of lung cancer. This is the third cancer drug to be developed on the basis of studies conducted by the Department of Immunology’s Prof. Michael Sela and colleagues.
Prof. Michael Sela
All three drugs are antibodies that block a receptor called the epidermal growth factor receptor, or EGFR. This receptor, which is on the surface of cells, plays a role in the formation and spread of cancerous tumors. Used in combination with chemotherapy or radiation, blocking EGFR may prevent cancer from growing. Prof. Sela and colleagues Drs. Esther Aboud-Pirak and Esther Hurwitz discovered, a number of years ago, that EGFR-inhibiting antibodies produce a synergistic anticancer effect when used together with chemotherapy.

TAGS: Genetics, Cancer, Cancer treatment, Clinical trials

Machine Learning IDs Blood-Cancer Cells Earlier Than Ever
Machine Learning IDs Blood-Cancer Cells Earlier Than Ever

https://www.weizmann-usa.org/news-media/in-the-news/machine-learning-ids-blood-cancer-cells-earlier-than-ever/

Jan 02, 2019... Tumor heterogeneity, clonal evolution and therapy resistance revealed using single-cell profiling of multiple myeloma patients. Illustration by Noa Godin/Weizmann Institute of Science
Israeli researchers have developed a new technology that profiles the genetic makeup of cancerous cells, allowing for better diagnosis and treatment.
Multiple myeloma is the second most-common type of blood cancer. Multiple myeloma occurs when plasma cells in the bone marrow – the cells that produce antibodies – proliferate out of control and lead to organ failure and death.

TAGS: Technology, Cancer, Cancer treatment, Blood

Cancer Drugs Could be Re-purposed to Fight Alzheimer’s Disease
Cancer Drugs Could be Re-purposed to Fight Alzheimer’s Disease

https://www.weizmann-usa.org/news-media/in-the-news/cancer-drugs-could-be-re-purposed-to-fight-alzheimer-s-disease/

Jan 18, 2016... Drugs which are already available on the NHS may help Alzheimer's patients, scientists believe Photo: Alamy
Cancer drugs already available on the NHS may help reverse Alzheimer’s disease by boosting the immune system, scientists believe.
A range of immunotherapy treatments, which harness the body’s own defences to ward off tumours are already revolutionising cancer care.
But now scientists believe that a similar immune boost could help people with dementia.

TAGS: Cancer treatment, Immune system, Alzheimers

Preventing Cancer: The Weizmann Institute's Moross Integrated Cancer Center
Preventing Cancer: The Weizmann Institute's Moross Integrated Cancer Center

https://www.weizmann-usa.org/news-media/video-gallery/preventing-cancer-the-weizmann-institute-s-moross-integrated-cancer-center/

Dec 22, 2015... The Weizmann Institute of Science's Moross Integrated Cancer Center (MICC) aims to revolutionize cancer prevention, detection, and treatments. Several of the senior scientists involved with the MICC – Prof. Zvi Livneh, Prof. Moshe Oren, Dr. Tamar Paz-Elizur, Dr. Eran Elinav, and Dr. Ayelet Erez – discuss directions in cancer prevention research.

TAGS: Genetics, Cancer, Cancer treatment

September is Prostate and Ovarian Cancer Awareness Month
September is Prostate and Ovarian Cancer Awareness Month

https://www.weizmann-usa.org/news-media/feature-stories/september-is-prostate-and-ovarian-cancer-awareness-month-1/

Sep 22, 2015... September is both Prostate Cancer Awareness Month and Ovarian Cancer Awareness Month. In the U.S., prostate cancer is the most common cancer (after skin cancer) in men: about 1 in 7 will be diagnosed during his lifetime. However, as the American Cancer Society points out, prostate cancer is now quite treatable, and “most men diagnosed with prostate cancer do not die from it.” But there is still progress to be made: for example, current treatments can have undesirable side effects, such as erectile dysfunction and urinary incontinence.The situation with ovarian cancer is rather reversed. It is far less common – a woman’s risk of being diagnosed is about 1 in 75 – but has much lower survival rates, largely because it is difficult to detect until it has spread. The American Cancer Society reports that only 15% of ovarian cancers are found and treated at the crucial early stages. Development of a reliable way to diagnose ovarian cancer is vital, as is a greater understanding of its tendency to aggressively metastasize and resist treatment.  Fortunately, multiple research groups at the Weizmann Institute of Science are investigating prostate and ovarian cancers. Here are just some of their advances:

TAGS: Cancer, Cancer treatment, Philanthropy

Rare Genetic Defect May Lead to Cancer Drug
Rare Genetic Defect May Lead to Cancer Drug

https://www.weizmann-usa.org/news-media/news-releases/rare-genetic-defect-may-lead-to-cancer-drug/

May 18, 2017... Dr. Ayelet Erez says that rare genetic diseases provide a lens on cancer
The path to understanding what goes wrong in cancer could benefit from a detour through studies of rare childhood diseases. Dr. Ayelet Erez explains that cancer generally involves dozens – if not hundreds – of mutations, and sorting out the various functions and malfunctions of each may be nearly impossible. Rare childhood diseases, in contrast, generally involve mutations to a single gene.

TAGS: Genetics, Cancer, Cancer treatment, Proteins

October is National Breast Cancer Awareness Month. How is Weizmann Helping?
October is National Breast Cancer Awareness Month. How is Weizmann Helping?

https://www.weizmann-usa.org/news-media/feature-stories/october-is-national-breast-cancer-awareness-month/

Oct 01, 2017... October is National Breast Cancer Awareness Month, and people everywhere are running, walking, and even shopping in support – and, at Israel’s Weizmann Institute of Science, investigating, researching, and pursuing creative new ways to attack this still-insidious, too-common disease.
The Weizmann Institute has a history of successfully fighting breast cancer; for example, the Susan G. Komen Breast Cancer Foundation supported early Weizmann research that helped develop Herceptin® (trastuzumab), one of the first – and most widely used – breast cancer drugs on the market. Today, thanks to the Institute’s new Moross Integrated Cancer Center, which will enable highly specific focus on individual cancers, breast cancer research will become ever more advanced and personalized.Here are just a few of our current investigations into breast cancer:

TAGS: Women, Cancer, Cancer treatment

Let There Be Light: Two Israeli Researchers Are Shining a Lethal Glow on Evasive Cancers
Let There Be Light: Two Israeli Researchers Are Shining a Lethal Glow on Evasive Cancers

https://www.weizmann-usa.org/news-media/in-the-news/let-there-be-light-two-israeli-researchers-are-shining-a-lethal-glow-on-evasive-cancers/

Jun 07, 2006... Between April 2004 and February 2005, 28 men with prostate cancer showed up at three Canadian hospitals for one-time injections of an experimental drug designed to eradicate their deadly tumors. Radiation had already failed them.
By December tumors in the earliest-treated patients had shrunk by as much as 84%. But the real test began in March, when doctors started studying tissue samples. If they find the tumors are gone or reduced to a manageable level, it may indicate that the drug is reliable over time, and researchers could be on their way to a radical advancement in localized prostate cancer treatment.

TAGS: Medicine, Cancer treatment

How Bacteria Could Protect Tumors From Anticancer Drugs
How Bacteria Could Protect Tumors From Anticancer Drugs

https://www.weizmann-usa.org/news-media/in-the-news/how-bacteria-could-protect-tumors-from-anticancer-drugs/

Sep 14, 2017... Bacteria, in green, inside a pancreatic cancer cell
Cancers have unwitting allies: the healthy cells that surround them. Several groups of scientists have now found that normal cells can inadvertently release substances that shield their malignant neighbors from anticancer drugs. That would explain why even targeted therapies—smart drugs that are meant to hit the specific genetic faults behind various cancers—sometimes stumble right out of the gate. When pitted against isolated cancer cells in laboratory tests, they perform as expected. But when pitted against actual tumors, which enjoy a kind of innate resistance because of the healthy cells around them, the drugs can fail.

TAGS: Cancer, Cancer treatment, Bacteria

First … 4 5 6 7 8 9 10 11 12 13 Last
Back Next
SHARE

Our Achievements

Learn more about remarkable Weizmann Institute achievements that are enhancing and transforming our lives.

Learn More

Support Our Flagship Projects

Help us accelerate exciting initiatives in three forward-looking fields: neuroscience, physics, and artificial intelligence.

Learn More

Newsletter

Get the latest news and breakthroughs from the Weizmann Institute of Science.

About Us
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
Our Achievements
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Get Involved
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
News & Media Blog: Curiosity Review Donate Now Contact Us
Privacy Policy Gift Acceptance Policy Financial Information

©2023 American Committee for the Weizmann Institute of Science

Charity Navigator

FOR THE FOURTH CONSECUTIVE YEAR

Platinum Transparency 2023